User profiles for DM Cirillo

Daniela Maria Cirillo

IRCCS San Raffaele Scientific Institute
Verified email at hsr.it
Cited by 40712

Macrophage‐dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival

DM Cirillo, RH Valdivia, DM Monack… - Molecular …, 1998 - Wiley Online Library
Salmonella pathogenicity island 2 (SPI‐2) encodes a putative type III secretion system necessary
for systemic infection in animals. We have investigated the transcriptional organization …

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

…, B Kan, I Solovic, R Duarte, DM Cirillo - European …, 2009 - Eur Respiratory Soc
Tuberculosis control relies on the identification and preventive treatment of individuals who
are latently infected with Mycobacterium tuberculosis. However, direct identification of latent …

Towards tuberculosis elimination: an action framework for low-incidence countries

…, R Centis, D Chemtob, DM Cirillo… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

[HTML][HTML] Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

…, B King, SL Hall, S Chakravorty, DM Cirillo… - The Lancet infectious …, 2018 - thelancet.com
Background The Xpert MTB/RIF assay is an automated molecular test that has improved the
detection of tuberculosis and rifampicin resistance, but its sensitivity is inadequate in …

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

…, C Rodrigues, A Skrahina, E Tagliani, DM Cirillo… - MBio, 2017 - Am Soc Microbiol
The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance
(RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-…

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

…, B Williams, WW Yew, JP Zellweger, DM Cirillo - 2014 - Eur Respiratory Soc
… Lange and DM Cirillo) and agreement by the TBNET steering committee, co-authors were
invited from among international experts in the field of MDR/XDR-TB (chapter leaders and …

Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis

…, L Coltella, G Lombardi, DM Cirillo - European …, 2012 - Eur Respiratory Soc
Extrapulmonary tuberculosis (EPTB) accounts for more than 20% of tuberculosis (TB) cases.
Xpert MTB/RIF (Xpert) (Cepheid, Sunnyvale, CA, USA) is a fully automated amplification …

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

…, R McNerney, M Ezewudo, DM Cirillo… - European …, 2017 - Eur Respiratory Soc
A clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis
is required to accelerate the development of rapid drug susceptibility testing methods …

Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages

…, NE Ntinginya, A Rachow, M Hoelscher, DM Cirillo… - Nature …, 2016 - nature.com
Generalist and specialist species differ in the breadth of their ecological niches. Little is known
about the niche width of obligate human pathogens. Here we analyzed a global collection …

Dynamic antibody responses to the Mycobacterium tuberculosis proteome

…, DM Molina, VT Huynh, DM Cirillo… - Proceedings of the …, 2010 - National Acad Sciences
Considerable effort has been directed toward controlling tuberculosis, which kills almost two
million people yearly. High on the research agenda is the discovery of biomarkers of active …